Fok I and Bsm I gene polymorphism of vitamin D receptor and essential hypertension: a mechanistic link

키워드

참고문헌 (68)

1. Lin L, "Vitamin D and vitamin D receptor : new insights in the treatment of hypertension", Curr Protein Pept Sci, 20, pp.984~995 (2019)
2. Kearney PM, "Global burden of hypertension : analysis of worldwide data", Lancet, 365, pp.217~223 (2005)
3. Saseen JJ, "Pharmacotherapy: a pathophysiologic approach", pp.87~101 (2014), McGraw-Hill
4. Scriabine A, "Comprehensive medicinal chemistry II", pp.705~728 (2007), Elsevier
5. Bell K, "Hypertension : the silent killer : updated JNC-8 guideline recommendations", Ala Pharm Assoc, 334, pp.4222~ (2015)
6. Warren HR, "Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk", Nat Genet, 49, pp.403~415 (2017)
7. Forman JP, "Plasma 25-hydroxyvitamin D levels and risk of incident hypertension", Hypertension, 49, pp.1063~1069 (2007)
8. Mithal A, "Global vitamin D status and determinants of hypovitaminosis D", Osteoporos Int, 20, pp.1807~1820 (2009)
9. Dusso AS, "Vitamin D", Am J Physiol Renal Physiol, 289, pp.F8~F28 (2005)
10. Mutchie TR, "Alternative binding sites at the vitamin D receptor and their ligands", Mol Cell Endocrinol, 485, pp.1~8 (2019)
11. Meyer MB, "Corepressors(NCoR and SMRT)as well as coactivators are recruited to positively regulated 1α, 25-dihydroxyvitamin D3-responsive genes", J Steroid Biochem Mol Biol, 136, pp.120~124 (2013)
12. Legarth C, "The impact of vitamin D in the treatment of essential hypertension", Int J Mol Sci, 19, pp.455~ (2018)
13. Prasad M, "Status of vitamin D receptor gene polymorphism and 25-hydroxy vitamin D deficiency with essential hypertension", Indian J Clin Biochem, 37, pp.335~341 (2022)
14. Miyamoto K, "Structural organization of the human vitamin D receptor chromosomal gene and its promoter", Mol Endocrinol, 11, pp.1165~1179 (1997)
15. Uitterlinden AG, "Genetics and biology of vitamin D receptor polymorphisms", Gene, 338, pp.143~156 (2004)
16. Laragh JH, "The plasma renin test reveals the contribution of body sodium-volume content(V)and renin-angiotensin(R)vasoconstriction to long-term blood pressure", Am J Hypertens, 24, pp.1164~1180 (2011)
17. Vaidya A, "The renin-angiotensin-aldosterone system and calcium-regulatory hormones", J Hum Hypertens, 29, pp.515~521 (2015)
18. Connell JM, "A lifetime of aldosterone excess : long-term consequences of altered regulation of aldosterone production for cardiovascular function", Endocr Rev, 29, pp.133~154 (2008)
19. Vaidya A, "The relationship between vitamin D and the reninangiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes", Metabolism, 61, pp.450~458 (2012)
20. Vaidya A, "Vitamin D and vascular disease : the current and future status of vitamin D therapy in hypertension and kidney disease", Curr Hypertens Rep, 14, pp.111~119 (2012)
21. Simpson RU, "Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse", J Steroid Biochem Mol Biol, 103, pp.521~524 (2007)
22. Zhou C, "Calcium-independent and 1, 25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice", Kidney Int, 74, pp.170~179 (2008)
23. Forman JP, "Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans", Hypertension, 55, pp.1283~1288 (2010)
24. Vaidya A, "25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians", J Renin-Angiotensin-Aldosterone Syst, 12, pp.311~319 (2011)
25. Carrara D, "Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D", J Renin-Angiotensin-Aldosterone Syst, 15, pp.82~87 (2014)
26. Vaidya A, "Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives : an interventional study", J Clin Endocrinol Metab, 97, pp.2456~2465 (2012)
27. Yuan W, "1, 25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter", J Biol Chem, 282, pp.29821~29830 (2007)
28. Burgess ED, "Interaction of 1, 25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension", Am J Hypertens, 3(12 Pt 1), pp.903~905 (1990)
29. Freundlich M, "Suppression of renin-angiotensin gene expression in the kidney by paricalcitol", Kidney Int, 74, pp.1394~1402 (2008)
30. Kuhlmann A, "1, 25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat", Am J Physiol Renal Physiol, 286, pp.F526~33 (2004)
31. Swapna N, "Risk conferred by FokI polymorphism of vitamin D receptor(VDR)gene for essential hypertension", Indian J Hum Genet, 17, pp.201~206 (2011)
32. Wang L, "A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men", Eur J Nutr, 52, pp.1771~1779 (2013)
33. Valdivielso JM, "Vitamin D receptor polymorphisms and diseases", Clin Chim Acta, 371, pp.1~12 (2006)
34. Liu S, "The role of vitamin D receptor gene polymorphisms in gestational diabetes mellitus susceptibility : a meta-analysis", Diabetol Metab Syndr, 13, pp.144~ (2021)
35. Tizaoui K, "Association between VDR polymorphisms and rheumatoid arthritis disease : systematic review and updated meta-analysis of case-control studies", Immunobiology, 220, pp.807~816 (2015)
36. Magiełda-Stola J, "The significance of VDR genetic polymorphisms in the etiology of preeclampsia in pregnant Polish women", Diagnostics, 11, pp.1698~ (2021)
37. Nam SW, "The associations between vitamin D receptor BsmI and ApaI polymorphisms and obesity in Korean patients with type 2 diabetes mellitus", Diabetes Metab Syndr Obes, 14, pp.557~564 (2021)
38. Abouzid M, "Vitamin D receptor gene polymorphism and vitamin D status in population of patients with cardiovascular disease : a preliminary study", Nutrients, 13, pp.3117~ (2021)
39. Eweida SM, "Vitamin D levels and vitamin D receptor genetic variants in Egyptian cardiovascular disease patients with and without diabetes", Egypt J Med Hum Genet, 22, pp.1~2 (2021)
40. Caccamo D, "Role of vitamin-D receptor(VDR)single nucleotide polymorphisms in gestational hypertension development : a case-control study", PLoS One, 15, pp.e0239407~ (2020)
41. Aristizabal-Pachon AF, "Association between VDR gene polymorphisms and melanoma susceptibility in a colombian population", Asian Pac J Cancer Prev, 23, pp.79~85 (2022)
42. Santoro D, "Association of VDR gene polymorphisms with heart disease in chronic kidney disease patients", Clin Biochem, 48, pp.1028~1032 (2015)
43. Zhu YB, "The association between vitamin D receptor gene polymorphism and susceptibility to hypertension : a meta-analysis", Eur Rev Med Pharmacol Sci, 23, pp.9066~9074 (2019)
44. Kulah E, "The relationship of target organ damage and 24-hour ambulatory blood pressure monitoring with vitamin D receptor gene Fok-I polymorphism in essential hypertension", Kidney Blood Press Res, 29, pp.344~350 (2006)
45. Abd El Gawad SS, "vitamin D receptor gene polymorphism and its association with 1,25-dihydroxyvitamin D3in patients with graves disease in an Egyptian population: a pilot study", Endocr Pract, 18, pp.132~139 (2012)
46. Arai H, "A vitamin D receptor gene polymorphism in the translation initiation codon : effect on protein activity and relation to bone mineral density in Japanese women", J Bone Miner Res, 12, pp.915~921 (1997)
47. Nunes IF, "Meta-analysis of the association between the rs228570 vitamin D receptor gene polymorphism and arterial hypertension risk", Adv Nutr, 11, pp.1211~1220 (2020)
48. Jurutka PW, "The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB", Mol Endocrinol, 14, pp.401~420 (2000)
49. Whitfield GK, "Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene", Mol Cell Endocrinol, 177, pp.145~159 (2001)
50. Wang L, "Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease : a meta-analysis of prospective studies", Circ Cardiovasc Qual Outcomes, 5, pp.819~829 (2012)
51. Liu JL, "ApaI, BsmI, FokI and TaqI polymorphisms in the vitamin D receptor(VDR)gene and the risk of psoriasis : a meta-analysis", J Eur Acad Dermatol Venereol, 27, pp.739~746 (2013)
52. Alizadeh S, "Common variants of vitamin D receptor gene polymorphisms and susceptibility to coronary artery disease : a systematic review and meta-analysis", J Nutrigenet Nutrigenomics, 10, pp.9~18 (2017)
53. Shi XY, "Association of vitamin D receptor gene variants with polycystic ovary syndrome : a meta-analysis", BMC Med Genet, 20, pp.32~ (2019)
54. Liu Y, "Polymorphisms in the vitamin D receptor(VDR)and the risk of ovarian cancer : a meta-analysis", PLoS One, 8, pp.e66716~ (2013)
55. Zhao J, "Association between VDR FokI polymorphism and intervertebral disk degeneration", Genomics Proteomics Bioinformatics, 13, pp.371~376 (2015)
56. Lu S, "The associations between the polymorphisms of vitamin D receptor and coronary artery disease : a systematic review and meta-analysis", Medicine, 95, pp.e3467~ (2016)
57. Cao Y, "Vitamin D receptor gene FokI polymorphisms and tuberculosis susceptibility : a meta-analysis", Arch Med Sci, 12, pp.1118~1134 (2016)
58. Jiao J, "Association of FokI, TaqI, BsmI and ApaI polymorphisms with diabetic retinopathy : a pooled analysis of casecontrol studies", Afr Health Sci, 18, pp.891~899 (2018)
59. Colin EM, "Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3", Clin Endocrinol(Oxf), 52, pp.211~216 (2000)
60. Cottone S, "Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals", J Hum Hypertens, 29, pp.483~487 (2015)
61. Muray S, "Influence of vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D on blood pressure in apparently healthy subjects", J Hypertens, 21, pp.2069~2075 (2003)
62. Lee BK, "Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes", Environ Health Perspect, 109, pp.383~389 (2001)
63. Nugroho P, "Association of BsmI polymorphisms in the vitamin D receptor gene among Indonesian population with diabetic kidney disease", Acta Med Indones, 53, pp.149~155 (2021)
64. Glocke M, "Impact of vitamin D receptor VDR rs2228570 polymorphism in oldest old", Kidney Blood Press Res, 37, pp.311~322 (2013)
65. Errouagui A, "Relationship with vitamin D receptor(RVD)gene and essential arterial hypertension in Moroccan population", Int J Innov Appl Stud, 8, pp.556~ (2014)
66. Jia J, "Vitamin D receptor genetic polymorphism is significantly associated with decreased risk of hypertension in a Chinese Han population", J Clin Hypertens(Greenwich), 16, pp.634~639 (2014)
67. Gussago C, "Impact of vitamin D receptor polymorphisms in centenarians", Endocrine, 53, pp.558~564 (2016)
68. Wang L, "Common genetic variations in the vitamin D pathway in relation to blood pressure", Am J Hypertens, 27, pp.1387~1395 (2014)

관련 논문AI추천